Kyron T 114 is a cross-linked methacrylic acid polymer specifically engineered as a high-performance taste masking agent for pharmaceutical applications. Its unique carboxylic acid functionality enables effective interaction with bitter compounds in active pharmaceutical ingredients, neutralizing unpleasant tastes without compromising drug efficacy. Manufactured under stringent quality controls, this polymer delivers consistent batch-to-batch performance and reliability. The product undergoes rigorous testing to ensure it meets the highest quality standards, providing manufacturers with a trusted solution for challenging taste-masking requirements in various oral formulations.

This polymer finds extensive application across pharmaceutical manufacturing sectors, particularly in oral solid and liquid dosage forms. It is indispensable in pediatric and geriatric medicines where taste acceptance significantly impacts treatment adherence. The nutraceutical and dietary supplement industries ...

Kyron T 114 is a cross-linked methacrylic acid polymer specifically engineered as a high-performance taste masking agent for pharmaceutical applications. Its unique carboxylic acid functionality enables effective interaction with bitter compounds in active pharmaceutical ingredients, neutralizing unpleasant tastes without compromising drug efficacy. Manufactured under stringent quality controls, this polymer delivers consistent batch-to-batch performance and reliability. The product undergoes rigorous testing to ensure it meets the highest quality standards, providing manufacturers with a trusted solution for challenging taste-masking requirements in various oral formulations.

This polymer finds extensive application across pharmaceutical manufacturing sectors, particularly in oral solid and liquid dosage forms. It is indispensable in pediatric and geriatric medicines where taste acceptance significantly impacts treatment adherence. The nutraceutical and dietary supplement industries utilize Kyron T 114 to enhance product appeal in chewable tablets, syrups, and suspensions. Veterinary pharmaceutical manufacturers rely on its consistent performance to ensure animal acceptance of oral medications. Generic drug producers and over-the-counter medicine manufacturers incorporate this polymer to meet consumer expectations for pleasant-tasting medications while maintaining regulatory compliance.

Kyron T 114 delivers substantial business value by enhancing product marketability and patient compliance, directly influencing commercial success. Its reliable performance reduces manufacturing variability and improves production efficiency through consistent batch-to-batch quality. The polymer's compatibility with various APIs and excipients minimizes formulation development time and costs. Manufacturers benefit from reduced product returns and increased customer satisfaction due to improved taste profiles. The proven efficacy in masking challenging bitter drugs provides competitive advantages in markets where taste differentiation matters.

Key Features:
- Cross-linked methacrylic acid polymer structure for stable performance
- Carboxylic acid functionality for effective bitter taste masking
- Rigorous quality testing ensures consistent batch-to-batch reliability
- Broad compatibility with various APIs and pharmaceutical excipients
- Proven efficacy in multiple oral dosage forms and delivery systems

Benefits:
- Improves patient compliance through effective taste masking
- Enhances product marketability and consumer acceptance
- Reduces formulation development time and costs
- Ensures consistent performance in manufacturing processes
- Maintains drug stability and therapeutic efficacy